Armistice Capital, LLC Dexcom Inc Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $918,661 - $1.17 Million	8,328 New	8,328 $944,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $6.19 Million - $8.3 Million	-58,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $1.94 Million - $2.59 Million	-24,000 Reduced 29.27%	58,000 $24.8 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $1.53 Million - $1.89 Million	18,000 Added 28.13%	82,000 $29.5 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $4.99 Million - $6.69 Million	64,000 New	64,000 $23.7 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.